#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Histopathological Diagnosis of Mitochondrial Myopathies – Indications and the Utility of Muscle Biopsy


Authors: O. Souček 1 ;  P. Ješina 2;  J. Zeman 2;  M. Elleder 3;  H. Hůlková 3;  Z. Lukáš 1
Authors‘ workplace: Ústav patologie LF MU a FN Brno 1;  Klinika dětského a dorostového lékařství 1. LF UK a VFN v Praze 2;  Ústav dědičných a metabolických poruch 1. LF UK a VFN v Praze 3
Published in: Cesk Slov Neurol N 2011; 74/107(4): 428-436
Category: Review Article

Overview

Mitochondrial myopathies make up a complex heterogenous group of diseases characte­rized by mitochondrial dysfunction. Mitochondrial disorders are caused biochemically, by impairment of the oxidative phosphorylation system formed by five multi-subunit polypeptide complexes (I-V) located within the inner mitochondrial membrane, along with two electron carriers (Q10 and cytochrome c). The electron carriers and complex II are nuclear DNA-encoded, while the remaining complexes are encoded both by nuclear and mitochondrial DNA. Classification of mitochondrial disorders is rendered complicated by clinical and genetic hete­rogeneity. Morphological examination is based on evaluation of the general pattern of histopathological changes in a muscle biopsy, of quantitative and qualitative alteration of the mitochondria and, last but not least, on assessment of the presence/absence of ragged red fibres in relation to the cytochrome c oxidase and succinyldehydrogenase reactivity. Combined with immunohistochemistry and in situ hybridisation, this may allow assessment of the type of heredity and/or point to a disorder in a certain complex of the oxidative phosphorylation chain.

Key words:
mitochondrial myopathy – muscle biopsy – diagnosis – classification


Sources

1. DiMauro S. Mitochondrial diseases. Biochim Biophys Acta 2004, 1658(2–3): 80–88.

2. DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update. Neuromuscul Disord 2005, 15(4): 276–286.

3. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283(1): 1482–1488.

4. Zeviani M. Mitochondrial disorders. Brain 2004; 127 (10): 2153–2172.

5. Munnich A, Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 2001; 106(1): 4–17.

6. Dubowitz V, Sewry CA. Muscle biopsy. A Practical Approach. London: Saunders Elsevier 2007.

7. Bednařík J et al. Nemoci kosterního svalstva. Praha: Triton 2001.

8. Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 2004, 14(4): 237–245.

9. Hasegawa H, Matsuoka T, Goto Y, Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Ann Neurol 1991; 29(6): 610–615.

10. Haller RG, Henriksson KG, Jorfeldt L, Hultman E, Wibom R, Sahlin K et al. Deficiency of skeletal muscle succinate dehydrogenase and aconitase: pathofysiology of exercise in a novel human muscle oxidative defect. J Clin Invest 1991; 88(4): 1197–1206.

11. Hall RE, Henriksson KG, Lewis SF, Haller RG, Kennaway NG. Mitochondrial myopathy with succinate dehydrogenase and aconitase deficiency: abnormalities of several iron-sulfur proteins. J Clin Invest 1993; 92(6): 2660–2666.

12. Lindal S, Lund I, Torbergsen T, Aasly J, Mellgren SI, Borud O et al. Mitochondrial diseases and myopathies: a series of muscle biopsy specimens with ultrasctructural changes in the mitochondria. Ultrastruct Pathol 1992; 16(3): 263–275.

13. Kyriacou K, Hadjisavvas A, Zenios A, Papacharalambous R, Kyriakides T. Morphological methods in the diagnosis of mitochondrial encephalomyopathies: the role of electron microscopy. Ultrastruct Pathol 2005; 29(3–4): 169–174.

14. Carpenter S, Karpáti G. Pathology of skeletal muscle. 2nd ed. New York: Oxford University Press 2001.

15. Bourgeois JM, Tarnopolsky MA. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion 2004; 4(5–6): 441–452.

16. Rifai Z, Welle S, Kamp C, Thornton CAl. Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol 1995; 37(1): 24–29.

17. Nelson RL, Prayson RA. Mitochondrial abnormalities and inclusion body myositis: a histopathologic and ultrastructural study of 36 patients. J Surg Pathol 1997; 2: 63–68.

18. Askanas V, Engel WK. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains. Acta Neuropathol 2008; 116(6): 583–595.

19. Yerroum M, Pham-Dang C, Authier FJ, Monnet I, Gherardi R, Chariot P. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myo­pathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits. Acta Neuropathol 2000; 100(1): 82–86.

20. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16(4): 481–488.

21. Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999; 341(14): 1037–1044.

22. Andreu AL, Tanji K, Bruno C, Hadjigeorgiou GM, Sue CM, Jay C et al. Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol 1999; 45(6): 820–823.

23. Horváth R, Schoser BGH, Müller-Höcker J, Völpel M, Jaksch M, Lochmüller Hl. Mutations in mt-DNA encoded cytochrome c oxidase subunit genes causing isolated myopathy or severe encephalomyopathy. Neuromuscul Disord 2005; 15(12): 851–857.

24. Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BG, Hans VH et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 2007; 130(8): 2037–2044.

25. Carta A, Carelli V, D‘Adda T, Ross-Cisneros FN, Sadun AA. Human extraocular muscles in mitochondrial diseases: comparing chronic progressive external ophthalmoplegia with Leber‘s hereditary optic neuropathy. Br J Ophthalmol 2005; 89(7): 825–827.

26. Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998; 20(4): 337–343.

27. Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998; 63(6): 1609–1621.

28. McFarland R, Clark KM, Morris AA, Taylor RW, Macphail S, Lightowlers RN et al. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 2002, 30(2): 145–146.

29. Taylor RW, Giordano C, Davidson MM, d‘Amati G, Bain H, Hayes CM et al. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypetrophic cardiomyopathy. J Am Coll Cardiol 2003; 41(10): 1786–1796.

30. Bresolin N, Zeviani M, Bonilla E, Miller RH, Leech RW, Shanske S et al. Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology 1985; 35(6): 802–812.

31. Tritschler HJ, Bonilla E, Lombes A, Andreetta F, Servidei S, Schneyder B et al. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology 1991; 41(1): 300–305.

32. DiMauro S, Lombes A, Nakase H, Mita S, Fabrizi GM, Tritschler HJ et al. Cytochrome c oxidase deficiency. Pediatr Res 1990; 28(5): 536–541.

33. Cacić M, Wilichowski E, Mejaski-Bosnjak V, Fumić K, Lujić L, Marusić Della Marina B et al. Cytochrome c oxidase partial deficiency-associated Leigh disease presenting as an extrapyramidal syndrome. J Child Neurol 2001; 16(8): 616–619.

34. De Paepe B, Smet J, Lammens M, Seneca S, Martin JJ, De Bleecker J et al. Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects. J Clin Pathol 2009; 62(2): 172–176.

Labels
Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery


2011 Issue 4

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#